Documents

Policy Brief Issue 26: Rare diseases – Talk of the Town for Some Time but What’s Next?

Policy Brief Issue 25: South Korea’s Experience of Reimbursing High-Cost Medicines

Policy Brief Issue 24: Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review

Policy Brief Issue 149: Health Financing during COVID-19 responses in Thailand

Policy Brief Issue 23: Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs

Factsheet: Who are the high cost users in Thailand’s Universal Coverage Scheme and how can we help?

Thinking of Creating a Chatbot in Public Health? Here are some tips and tricks for you

Recommended Health Screening Packages under Universal Health Coverage

Navigating the Landscape of Digital Health: Indonesia

Navigating the Landscape of Digital Health: Singapore

Navigating the Landscape of Digital Health: United Kingdom

Full report: A Cost Analysis of Key Population Interventions to Fast Track the End of the HIV Epidemic in Thailand

Full report: Guidance on use of modelling for policy responses to COVID-19

การประเมินเทคโนโลยีด้านสุขภาพโดยคณะทำงานด้านเศรษฐศาสตร์สาธารณสุข ภายใต้คณะอนุกรรมการพัฒนาบัญชียาหลักแห่งชาติ รอบปี พ.ศ. 2559-2561

การจัดหายาของโรงพยาบาลรัฐตามพระราชบัญญัติการจัดซื้อจัดจ้างและการบริหารพัสดุภาครัฐ พ.ศ.2560

Situation of Data and Pharmaceutical Information Systems in Thailand

การทบทวนและพัฒนาข้อเสนอเพื่อการปรับปรุงชุดสิทธิประโยชน์ภายใต้บัตรประกันสุขภาพคนต่างด้าว

Application of HTA Research on Policy Decision-Making (2014)

How Many People Experience Unsafe Medical Care in Thailand, and How Much Does It Cost under Universal Coverage Scheme?

Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline

Economic Evaluation of Evusheld® for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand

Economic Analysis of Border Control Policies during COVID-19 Pandemic: A Modelling Study to Inform Cross-Border Travel Policy between Singapore and Thailand

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance

Special English Edition of HITAP newsletter (Jan-Apr 2016) : Priority Setting for Universal Health Coverage

Annual report 2015

Portfolio Health Intervention and Technology Assessment Program (HITAP)

Annual report 2011

Annual report 2010

Annual report 2009

18th HTAsiaLink Newsletter: The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions

17th HTAsiaLink Newsletter: Bridge to the Future – Horizon Scanning for Emerging Health Technology

16th HTAsiaLink Newsletter: Lessons from the Pandemic for HTA

15th HTAsiaLink Newsletter: How to optimise HTA usage in healthcare crisis?

14th HTAsiaLink Newsletter: Non-communicable diseases and COVID-19

Report: Unit for Health Evidence and Policy (UHEP) Second Stakeholder Consultation and HTA Topic Prioritisation Workshop

Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan

Mission Report: GAVI HSS Study: Workshop on Reflecting on Data Collection for GAVI HSS Study

Mission Report: Tata Memorial Platinum Jubilee Conference

Mission Report: Formalizing Process: HTA Introduction and Topic Nomination Workshop